Sponsored Test
Amyotrophic Lateral Sclerosis (ALS) Testing Program
29 genes
2 - 3 weeks
Notice
This program will no longer accept samples after January 16th, 2026.
- Samples received on or before January 16th, 2026 will be processed and results will be provided as usual.
- Samples received after January 16th, 2026 will not be tested. If this occurs, PreventionGenetics will notify you to discuss possible next steps.
To order ALS genetic testing after this date, please:
- Consider the PreventionGenetics ALS Panel or ALS and Frontotemporal Dementia (FTD) Panel
- Contact your PreventionGenetics representative to discuss genetic testing options for ALS
For questions regarding results interpretation for testing completed under this program, a PreventionGenetics representative is available to assist you at Support@preventiongenetics.com
Ionis remains committed to advancing research and supporting the ALS community through ongoing publications in genetic testing and genetic counseling.
MED-CA-GEN-2500006 v1.0 12/2025
Test Criteria | Candidates for this test are patients in the U.S. and Canada with a clinical or suspected clinical diagnosis of ALS (with or without a family history), or who are pre-symptomatic WITH a family history of ALS. No unaffected patient under 18 are offered pre-symptomatic testing. All symptomatic patients under 18 must have clinical features documented on the order. An exception would be considered if there is a known, familial, adolescent or pediatric form of rapidly progressive ALS. |
Specimen(s) | Whole blood, saliva, OCD-100 Buccal Swab |
Experienced support at every step
Our team of experts can help you explore testing options, place an order, ship a sample, and understand results.